Novartis’ Lucentis
(ranibizumab) has been PBS listed
today for diabetic macular oedema
and retinal vein occlusion.
The anti-vascular endothelial
growth factor (VEGF) works by
preventing damaged or blocked
blood vessels from leaking fluid into
the macula and thereby reducing
ocular swelling.
The July PBS website update
has been posted with other
key additions including Xalkori
(crzotinib), Vimpat (lacosamide)
and a range of generic brands.The above article was sent to subscribers in Pharmacy Daily's issue from 01 Jul 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Jul 15
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.